136 related articles for article (PubMed ID: 38490075)
1. A national registry-based study of ethnic differences in people with multiple sclerosis in Iran.
Ashtari F; Kavosh A; Baghbanian SM; Hosseini Nejad Mir N; Hosseini S; Razazian N; Majdinasab N; Farajzadegan Z; Shaygannejad V; Adibi I; Eskandarieh S; Sahraian MA
Clin Neurol Neurosurg; 2024 Apr; 239():108216. PubMed ID: 38490075
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Ashtari F; Baghbanian SM; Razazian N; Moghadasi AN; Bayati A; Azimi AR; Beladimoghadam N; Harirchian MH; Poursadeghfard M; Navardi S; Shirkoohi R; Heidari H; Ghaffari M; Eskandarieh S
BMC Neurol; 2022 Mar; 22(1):76. PubMed ID: 35248009
[TBL] [Abstract][Full Text] [Related]
3. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 49 autosomal SNPs in three ethnic groups from Iran: Persians, Lurs and Kurds.
Sharafi Farzad M; Tomas C; Børsting C; Zeinali Z; Malekdoost M; Zeinali S; Morling N
Forensic Sci Int Genet; 2013 Jul; 7(4):471-3. PubMed ID: 23648204
[TBL] [Abstract][Full Text] [Related]
5. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
6. Time interval between the onset of symptoms and diagnosis of multiple sclerosis and the influential factors: A national registry-based study.
Khodaie F; Moghadasi AN; Hosseinnataj A; Baghbanian SM; Ashtari F; Razazian N; Poursadeghfard M; Majdi-Nasab N; Hatamian H; Hoseini S; Nahayati MA; Nabavi SM; Faraji F; Harirchian MH; Mir NHN; Moghadam NB; Sharifipour E; Bayati A; Kamali H; Mozhdehipanah H; Jalali N; Abotorabi-Zarchi M; Kamyari N; Nikbakht R; Azimi A; Navardi S; Heidari H; Sahraian MA; Eskandarieh S
Clin Neurol Neurosurg; 2024 Apr; 239():108221. PubMed ID: 38447483
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
8. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
[TBL] [Abstract][Full Text] [Related]
9. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
[TBL] [Abstract][Full Text] [Related]
10. The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Sharmin S; Roos I; Simpson-Yap S; Malpas C; Sánchez MM; Ozakbas S; Horakova D; Havrdova EK; Patti F; Alroughani R; Izquierdo G; Eichau S; Boz C; Zakaria M; Onofrj M; Lugaresi A; Weinstock-Guttman B; Prat A; Girard M; Duquette P; Terzi M; Amato MP; Karabudak R; Grand'Maison F; Khoury SJ; Grammond P; Lechner-Scott J; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Turkoglu R; Altintas A; Maimone D; Kermode A; Shalaby N; Pesch VV; Butler E; Sidhom Y; Gouider R; Mrabet S; Gerlach O; Soysal A; Barnett M; Kuhle J; Hughes S; Sa MJ; Hodgkinson S; Oreja-Guevara C; Ampapa R; Petersen T; Ramo-Tello C; Spitaleri D; McCombe P; Taylor B; Prevost J; Foschi M; Slee M; McGuigan C; Laureys G; Hijfte LV; de Gans K; Solaro C; Oh J; Macdonell R; Aguera-Morales E; Singhal B; Gray O; Garber J; Wijmeersch BV; Simu M; Castillo-Triviño T; Sanchez-Menoyo JL; Khurana D; Al-Asmi A; Al-Harbi T; Deri N; Fragoso Y; Lalive PH; Sinnige LGF; Shaw C; Shuey N; Csepany T; Sempere AP; Moore F; Decoo D; Willekens B; Gobbi C; Massey J; Hardy T; Parratt J; Kalincik T
Brain; 2023 Nov; 146(11):4633-4644. PubMed ID: 37369086
[TBL] [Abstract][Full Text] [Related]
11. Disease-modifying treatment, long-term outcomes and transition to progressive multiple sclerosis: data based on the New York State MS Consortium.
Jakimovski D; Kavak KS; Coyle PK; Goodman AD; Gottesman M; Zivadinov R; Weinstock-Guttman B;
J Neurol; 2024 Feb; 271(2):711-722. PubMed ID: 37995009
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran.
Dabiri H; Maleknejad P; Yamaoka Y; Feizabadi MM; Jafari F; Rezadehbashi M; Nakhjavani FA; Mirsalehian A; Zali MR
J Gastroenterol Hepatol; 2009 Aug; 24(8):1380-6. PubMed ID: 19702906
[TBL] [Abstract][Full Text] [Related]
13. Population and forensic data for three sets of forensic genetic markers in four ethnic groups from Iran: Persians, Lurs, Kurds and Azeris.
Poulsen L; Farzad MS; Børsting C; Tomas C; Pereira V; Morling N
Forensic Sci Int Genet; 2015 Jul; 17():43-46. PubMed ID: 25814339
[TBL] [Abstract][Full Text] [Related]
14. Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Deri N; Barboza A; Vrech C; Rey R; Burgos M; Fiol M; CalvoVildoso C; Patrucco L; Jose G; Aliberti P; Chirico D; Federico MB; Seifer G; Piedrabuena R
Mult Scler Relat Disord; 2024 Mar; 83():105421. PubMed ID: 38244525
[TBL] [Abstract][Full Text] [Related]
15. Familial vs sporadic multiple sclerosis in the Israeli population: Differences in ethnicity distribution and disease progression, with anticipation in successive generations.
Kugelman N; Staun-Ram E; Volkovitz A; Barnett-Griness O; Glass-Marmor L; Miller A
Mult Scler Relat Disord; 2024 Jul; 87():105604. PubMed ID: 38718750
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors.
Etemadifar M; Salari M; Esnaashari A; Ghazanfaripoor F; Sayahi F; Akhavan Sigari A; Sedaghat N
Mult Scler Relat Disord; 2022 Feb; 58():103488. PubMed ID: 34999375
[TBL] [Abstract][Full Text] [Related]
17. Muscle Quality of Knee Extensors Based on Several Types of Force in Multiple Sclerosis Patients with Varying Degrees of Disability.
Portilla-Cueto K; Medina-Pérez C; Romero-Pérez EM; Núñez-Othón G; Horta-Gim MA; de Paz JA
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208639
[No Abstract] [Full Text] [Related]
18. Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis.
Rzepiński Ł; Kośliński P; Kowalewski M; Koba M; Maciejek Z
Neurol Neurochir Pol; 2023; 57(5):414-422. PubMed ID: 37526173
[TBL] [Abstract][Full Text] [Related]
19. Clinical and demographic characteristics of late-onset multiple sclerosis: LOMS-TR study.
Sıvacı AÖ; Seferoğlu M; Piri Çınar B; Uzunköprü C; Beckmann Y; Güngör Doğan İ; Çetinkaya Tezer D; Tunç A; Ethemoğlu Ö; Gümüş H; Açıkgöz M; Yalaz Tekan Ü; Demir S
Mult Scler Relat Disord; 2024 Apr; 84():105469. PubMed ID: 38341979
[TBL] [Abstract][Full Text] [Related]
20. Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors.
Iaffaldano P; Lucisano G; Patti F; Brescia Morra V; De Luca G; Lugaresi A; Zaffaroni M; Inglese M; Salemi G; Cocco E; Conte A; Ferraro D; Galgani S; Bergamaschi R; Pozzilli C; Salvetti M; Lus G; Rovaris M; Maniscalco GT; Logullo FO; Paolicelli D; Achille M; Marrazzo G; Lovato V; Comi G; Filippi M; Amato MP; Trojano M;
Mult Scler; 2021 Mar; 27(3):430-438. PubMed ID: 33210986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
